Can Frozen Embryo Transfer Be Performed in Chinese IVF? Conditions, Process, and Clinical Decision-Making

========== AI Summary ==========

========== Main Content Begins ==========

Opening: Real Consultation Scenario

Module A: Direct Answer to the Question

Frozen Embryo Transfer: A Standard Option in Chinese Fertility Centers

All medical institutions in China with assisted reproductive technology qualifications perform frozen embryo transfer. FET involves preserving embryos in liquid nitrogen using vitrification technology and thawing them for transfer into the uterus in a subsequent cycle. Currently, FET and fresh embryo transfer are both standard transfer protocols, and the clinical choice depends on the patient's specific situation.

Main scenarios for FET include:

• High OHSS Risk — High estrogen levels after egg retrieval or a large number of follicles; pregnancy after transfer can worsen OHSS, and FET significantly reduces this risk.
• Poor Endometrial Receptivity — Suboptimal endometrial morphology, thickness, or blood flow after egg retrieval, or conditions like endometrial polyps or intrauterine fluid.
• Waiting for PGT Results — Embryo genetic testing (PGT-A/PGT-M/PGT-SR) is required, which takes about 2–4 weeks.
• Premature Progesterone Rise — Elevated progesterone before egg retrieval suggests the implantation window may have shifted; FET allows waiting for a more suitable endometrial cycle.
• Large Number of Embryos — Multiple transferable embryos obtained from one stimulation cycle; transferring them in batches via FET can improve cumulative live birth rates.

Module C: The Doctor's Perspective

Clinical Decision-Making Logic of Reproductive Specialists

In reproductive medicine, the core consideration when choosing between fresh and frozen embryo transfer is the balance between safety and efficiency. From a clinical perspective, doctors will prioritize FET in the following situations:

• OHSS Risk Stratification — For patients at high risk of OHSS (PCOS, AMH >5 ng/mL, antral follicle count >20, estradiol >4000 pg/mL), FET is a key measure to avoid moderate to severe OHSS.
• Endometrial-Embryo Synchrony — In the stimulation cycle, supraphysiological estrogen levels may alter endometrial receptivity. FET allows more precise control of endometrial preparation in a natural or artificial cycle, synchronizing the embryo with the implantation window.
• PGT Requirement — Waiting for genetic results after embryo biopsy makes FET the only feasible option.
• Previous Repeated Implantation Failure — For patients with a history of repeated fresh transfer failures, FET combined with adjusted endometrial preparation protocols may improve outcomes.

It is important to clarify that FET is not suitable for everyone. Doctors may lean towards fresh transfer in the following cases: good endometrial conditions, low OHSS risk, normal embryo development without PGT needs, and patients wishing to shorten the time to pregnancy.

Module I: Actual Procedure

Complete Process of Frozen Embryo Transfer

The FET process consists of five main steps, each with clinical decision points.

Step 1: Choosing an Endometrial Preparation Protocol

Endometrial preparation is the foundation of successful FET. Three main protocols are used clinically:

The choice of protocol depends on the patient's menstrual status, ovulatory function, history of endometrial response, and personal schedule. There is no absolute best protocol; individualization is the core principle.

Step 2: Endometrial Monitoring and Assessment

Regardless of the protocol, transvaginal ultrasound is used to monitor endometrial thickness, morphology, blood flow, and hormone levels. Common clinical assessment indicators include:

• Endometrial Thickness — Usually requires ≥7 mm, but thickness is not the only criterion; patients with >6.5 mm and good blood flow can also achieve good pregnancy rates.
• Endometrial Morphology — Type A (triple-line sign) usually indicates good receptivity; Types B and C require comprehensive evaluation with other indicators.
• Endometrial Blood Flow — Assessed by color Doppler; Resistance Index (RI) <0.7 indicates low resistance.
• Hormone Levels — Estradiol reflects endometrial proliferation; progesterone confirms the timing of endometrial transformation.

Step 3: Embryo Thawing

Vitrification is the mainstream embryo freezing method. The thawing process is completed in the lab, taking about 30–60 minutes. Survival rates correlate with embryo quality:

• Good quality embryos (e.g., Grade A or B blastocysts): survival rate >98%
• Average quality embryos: survival rate approx. 90–95%
• Embryos that survive but have some cell damage are cultured for 2–4 hours to assess suitability for transfer

Step 4: Transfer Procedure

FET is performed in an outpatient operating room; no hospitalization is required. The procedure takes about 5–10 minutes, using abdominal ultrasound guidance to place the embryo transfer catheter through the cervix into the uterine cavity. Patients rest for 20–30 minutes after the procedure before leaving.

Step 5: Luteal Support

Luteal support after transfer is a crucial part of the FET cycle. Common medications include oral dydrogesterone, vaginal progesterone gel, and intramuscular progesterone injections. Luteal support generally continues until 12–14 days after transfer; the regimen is adjusted based on pregnancy status.

Module G: Most Easily Overlooked Details

Most Easily Overlooked Clinical Details

• Impact of Embryo Freezing Duration — With vitrification, the duration of freezing (from months to years) has no significant effect on survival and pregnancy rates. However, attention must be paid to legal documents and informed consent for cryopreservation.
• Determining Transfer Day — In a natural cycle, transfer is on day 5 after ovulation (blastocyst) or day 3 (cleavage stage); in an artificial cycle, transfer is on day 5 or 6 after starting progesterone. Incorrect calculation leads to asynchrony between the embryo and endometrium.
• Individualized Luteal Support Adjustment — Patients vary in absorption and response to luteal support medications. Vaginal users should be aware of drug residue affecting ultrasound images; intramuscular users should monitor for local induration and absorption issues.

Module H: Common Pitfalls

Common Misconceptions About Frozen Embryo Transfer

• Misconception 2: Longer freezing time degrades embryo quality — Vitrification puts embryos into a state of “metabolic arrest,” theoretically allowing long-term storage. Current literature reports no significant decline in survival and pregnancy rates for embryos cryopreserved for up to 5 years.
• Misconception 3: Hysteroscopy is unnecessary in an FET cycle — For patients with repeated FET failure (≥2 times), hysteroscopy is essential. Conditions like endometrial polyps, chronic endometritis, and intrauterine adhesions are easily missed on routine ultrasound.
• Misconception 4: Prolonged bed rest is needed after transfer — Extensive research confirms that prolonged bed rest does not improve pregnancy rates and may increase anxiety and thrombosis risk. Normal daily activities are fine, avoiding strenuous exercise and heavy lifting.

Module L: Interpretation of Key Tests

Clinical Significance of Key Test Indicators

In an FET cycle, the interpretation of the following indicators directly impacts decision-making:

Module N: Special Situations

FET Strategies for Special Populations

Repeated Implantation Failure (RIF)

For patients who have failed to conceive after ≥3 transfers of good quality embryos, systematic investigation is recommended:

• Hysteroscopy + endometrial biopsy (check for chronic endometritis, CD138+ cells)
• Endometrial microbiome analysis (Lactobacillus ratio <90% may affect receptivity)
• Immunological tests (NK cell activity, thyroid antibodies, antiphospholipid antibodies, etc.)
• Embryo genetic testing (PGT-A, screening for chromosomal aneuploidy)

Advanced Maternal Age (≥38 years)

The rate of embryonic aneuploidy increases with age. FET combined with PGT-A can select chromosomally normal embryos, improving efficiency per transfer. However, PGT-A does not increase cumulative live birth rates but reduces the number of ineffective transfers.

Thin Endometrium (<6 mm)

Management of refractory thin endometrium includes: escalating estrogen dose regimens, intrauterine infusion of growth hormone (GH), using ovulation induction cycles to utilize endogenous estrogen from follicles, and intrauterine stem cell therapy (still in clinical research). FET is more suitable for patients with thin endometrium than fresh transfer because it allows flexible timing of endometrial preparation.

Module Q: Frequently Asked Questions

High-Frequency Patient Questions

Module R: Practitioner Observations

Practitioner Observations: Clinical Trends in FET

In the field of assisted reproduction, the proportion of FET cycles is increasing annually. Data from some large domestic fertility centers show that the proportion of FET cycles has risen from 35% in 2015 to 55%–60% in 2023. This change is mainly driven by the following factors:

• Promotion of the “freeze-all” strategy — For patients at high risk of OHSS, freezing all embryos and performing transfer in a subsequent cycle has become the standard protocol.
• Widespread use of PGT — More patients choose embryo genetic testing, making FET a necessary step.
• Maturation of vitrification technology — Survival rates are consistently above 95%, significantly increasing acceptance among clinicians and patients.
• Individualization of endometrial preparation protocols — The flexibility of artificial and ovulation induction cycles allows FET to better match endometrial receptivity.

In terms of clinical outcomes, live birth rates with FET are now comparable to fresh transfer, and in certain populations (e.g., high OHSS risk, PCOS, poor endometrial receptivity), FET may even be superior. However, it is important for patients to fully understand the time cost of an FET cycle and the minimal risk of embryo loss during freezing and thawing.

Conclusion: Doctor's Advice

Doctor's Advice

Risk Reminder